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Abstract Ecto-50-nucleotidase (ecto-50-NT) is attached
via a GPI anchor to the extracellular membrane,
where it hydrolyses AMP to adenosine and phosphate.
Related 50-nucleotidases exist in bacteria, where they
are exported into the periplasmic space. X-ray struc-
tures of the 50-nucleotidase from E. coli showed that
the enzyme consists of two domains. The N-terminal
domain coordinates two catalytic divalent metal ions,
whereas the C-terminal domain provides the substrate
specificity pocket for the nucleotides. Thus, the sub-
strate binds at the interface of the two domains. Here,
the currently available structural information on ecto-
50-NT is reviewed in relation to the catalytic properties
and enzyme function.




50-nucleotidases (50-NT, E.C. 3.1.3.5) catalyse the
hydrolysis of the phosphoric ester bond of 50-ribonu-
cleotides to the corresponding ribonucleoside and
phosphate. These enzymes have been found in bacteria,
animals and plants and they display significant differ-
ences in the range of substrates hydrolysed. In the
animal enzymes one has to distinguish between the cy-
tosolic and the extracellular, surface-located ecto-
enzymes, which are structurally unrelated [1]. Cytosolic
50-NT controls the intracellular levels of nucleoside 50-
monophosphates.
On the basis of the primary sequence homology it
became clear that ecto-50-NT is related to the bacterial
50-nucleotidases. Characteristic sequence motifs
showed furthermore, that the enzyme belongs to a
superfamily of metallophosphoesterases with a dinu-
clear metal center [2].
The main function of 50-NT is the hydrolysis of
AMP to adenosine. It is thus part of the cascade
(together with ecto-ATPases) to terminate the action
of nucleotides such as ATP as extracellular signalling
molecules acting on P2X and P2Y receptors [3]. On
the other hand, the enzyme generates adenosine,
which acts on P1 receptors. There is evidence for a
coordinated induction and repression of ecto-50-NT
and the A2a adenosine receptor in human B-cell lines
[4]. The enzyme is also important for the recycling of
extracellular nucleotides, which are converted to
nucleosides by 50-NT and internalized through specific
nucleoside transporters. Purinergic receptor signalling
is involved in very diverse biological processes including
neurotransmission, platelet aggregation, modulation of
the immune response, smooth muscle contraction as
well as the control of cell proliferation, differentiation
and apoptosis [5, 6]. Specific inhibitors against the
hydrolytic enzymes including 50-NT and synthetic
ligands acting as agonists or antagonists of the puriner-
gic receptors have therapeutic potential. Like other
surface-located enzymes, ecto-50-NT, also known as
CD73, has been implicated in non-enzymatic functions
such as T-cell activation and cell–cell adhesion [7, 8].
Purinergic Signalling (2006) 2:343–350
DOI 10.1007/s11302-006-9000-8
N. Stra¨ter (*)
Center for Biotechnology and Biomedicine,
University of Leipzig,
Deutscher Platz 5, 04103 Leipzig, Germany
e-mail: strater@bbz.uni-leipzig.de
Catalytic properties
50-NT shows no activity towards nucleoside 20- and 30-
monophosphates ([5] and references therein). The
hydrolysis of 50-AMP is stereoselective, since the L-
enantiomer is no substrate [9]. The Km values for 5
0-
AMP as the best substrate are in the low micromolar
range. ADP and ATP are competitive inhibitors, with
inhibition constants also in the low micromolar range.
This indicates that they bind similarly to the active site
but cannot be hydrolyzed. This is in contrast to E. coli
50-NT which hydrolyses AMP, ADP, and ATP and
other 50-ribo- and 50-deoxyribonucleotides [10, 11].
The bacterial enzyme also hydrolyzes the artificial
substrate p-nitrophenyl phosphate, which is not a
substrate for ecto-50-NT [5]. On the other hand,
purified 50-NT from the electric ray hydrolyses UDP-
glucose as does E.coli 50-NT [12]. The bacterial as well
as the vertebrate enzymes show no product inhibition
by phosphate, in contrast to the related purple acid
phosphatases and Ser/Thr protein phosphatases. The
pH optimum is between 7 and 8. A comprehensive
reference to the molecular and kinetic characterisation
of 50-NT until 1992 is found in [5].
Structural properties
Determination of the primary structures of ecto-50-NT
from human placenta [13], rat liver [14] and the
electric ray fish [12] showed that the mature enzyme
consists of 548 amino acids with a calculated molecular
mass of 61 kDa. A stretch of õ25 hydrophobic residues
at the C-terminus is replaced by a glycosyl phosphati-
dylinositol (GPI) anchor, by which the mature protein
is attached to the cell membrane via the C-terminal
serine residue linked to a complex oligoglycan and a
sphingolipidinositol group [15]. No protein segments
are embedded within the membrane [16]. Soluble
forms of the enzyme exist [17–19], which are derived
from the membrane-bound form by hydrolysis of the
GPI anchor by phosphatidylinositol-specific phospho-
lipase [18, 20] or by proteolytic cleavage [19]. Chicken
gizzard 50-NT also binds with high affinity to the
laminin/nitogen complex [21].
The mammalian enzymes display a sequence iden-
tity of slightly more than 20% to the bacterial
enzymes, indicating a common ancestry and similar
structures. On the basis of short sequence motifs it
became clear that ecto-50-NT belongs to a large
superfamily of distantly related metallophosphoes-
terases acting on diverse substrates such as Ser/Thr
phosphoproteins, various nucleotides, sphingomyelin,
as well as RNA and DNA [2]. The first crystal
structures of these metallophosphatases, a plant purple
acid phosphatase [22] and mammalian Ser/Thr protein
phosphatases [23–26] showed a common core fold
consisting of four layers with two mixed sandwiched
b-sheets flanked by a-helices (layers abba). Two metal
ions are present in the catalytic center.
For ecto-50-NT isolated from three different sources
Fini et al. [27] determined a metal content of two zinc
ions per dimer, indicating that at least one of the two
metal binding sites is occupied by zinc. For the
monomeric E. coli 50-NT two bound zinc ions have
been determined [28]. This finding is in contrast to
earlier studies where a zinc/protein ratio of 0.7 has
been found [29]. Possibly, part of the metal has been
dissociated due to the low binding affinity of one metal
site. Different metal binding affinity of the dimetal
center is supported by kinetic and mutational as well
as crystallographic data [28, 30]. Analysis of metal
activation of variants with mutated metal ligands
indicates that M2 has a lower affinity for Zn2+ and
that it is the site of Co2+-activation [28]. M1 has a
lower affinity for Mn2+ compared to M2, as shown by
the occupancy of the metal binding sites in the crystal.
Bovine and rat ecto-50-NT display the largest cata-
lytic activity by activation with cobalt ions [29, 31],
similar to the E. coli enzyme [10, 28, 32], whereas
electric ray 50-NT is maximally activated by Mg2+ and
Ca2+ [33].
Ecto-50-NT forms homodimers [34, 35], which are
not linked by cystine bridges [36]. In the enzyme from
bull seminal plasma, the eight cysteines are all
involved in intramolecular disulfide bridges of the fol-
lowing pairs: Cys51–Cys57, Cys353–Cys358, Cys365–
Cys387 and Cys476–Cys479 [37]. For this enzyme the
N-glycosylation of Asn53, Asn311, Asn333 by high-
mannose saccharide chains and of Asn403 by a mixture
of high mannose and complex type glycans amounted
to õ6 kDa molecular weight of the 65.6 kDa protein.
The glycosylation is highly heterogenous, especially at
Asn403 and the resulting isoforms differ significantly
in substrate specificity and catalytic activity [19].
3D structure
A crystal structure is available for E. coli 50-NT (Fig. 1)
[38]. The enzyme consists of two domains: The N-
terminal domain (residues 25–342) binds the two metal
ions and contains an Asp–His dyad, which are im-
portant for the catalytic activity. This domain is related
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to other known enzyme structures of the calcineurin
superfamily of dimetal phosphoesterases and it has the
characteristic four-layered fold described above. The
C-terminal domain (residues 362–550) has a unique
structure, which has so far not been found in other
protein structures. This domain provides the binding
site for the adenosine moiety of the substrate. Thus,
the active site is located between the two domains. A
long a-helix (residues 343–361) connects the two
domains.
In the crystal structures, the protein has been
characterised in two different conformations, which
differ in the relative orientation of the two domains
[39]. The domain movement can be described as a
rotation of the C-terminal domain around the axis
shown in Fig. 1, which passes through the center of the
C-terminal domain. A rotation of up to 96- is
necessary for the change between the inactive open
and the active closed conformation. The domain
rotation is necessary for the catalytic action of the
enzyme, presumably to allow for substrate binding and
product release [40, 41].
A model for the mammalian ecto-nucleotidases
A sequence alignment of E. coli 50-NT and the
mammalian ecto-enzymes shows that both domains
are conserved and a homology model can be built for
ecto-50-NT (Figs. 2 and 3). The alignment shown in
Fig. 2 is manually edited based on an automated
sequence alignment and based on information from
the generated models in order to fulfill structural
constraints such as the possibility to form the known
cystine bridges [37] and the necessary insertions and
deletions.
In this model the loop from residue 319 to 337 in the
E. coli enzyme, stabilized by two interacting b-strands,
is missing in ecto-50-NT (L1 in Fig. 3). This loop is
pointing away from the enzyme and has few inter-
actions with the protein. Its function is unknown. The
nearby loop around residue 50 is longer in the
mammalian enzyme (L2). It is stabilized by a cystine
bridge (51–57) and carries a glycosylation on Asn53.
On the other side of the protein, three loops are
predicted to differ significantly between the mamma-
lian and bacterial nucleotidases. The loop near residue
146 in E. coli (L3) is longer in the mammalian enzymes
whereas the short helix at residue 183 in E. coli 50-NT
is missing (L4). In the C-terminal domain two inser-
tions are predicted to be present in ecto-50-NT: At
residue 482 (L5) and 398 (L6) of the bacterial
sequence. The loop around residue 228 in E.coli 50-
NT is significantly shorter in ecto-50-NT (L7). Further
smaller insertions and deletions are present in the
model.
Fig. 1 Fold of E. coli 50-NT. (a) Open form in complex with ATP (b) Closed form with the inhibitor a,b-methylene-ADP bound to the
active site. The substrate and inhibitor are shown in blue. ATP is bound to the same binding site of the C-terminal domain in the open
form as the inhibitor in the closed form. The substrate rotates with the C-terminal domain into the proximity of the dimetal center
(shown in light blue) by a 96--domain rotation around the axis depicted in green. The N-terminal domain is coloured in yellow, the C-
terminal domain in red and the bending residues of the hinge region in green.
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The mammalian enzymes form dimers, whereas the
bacterial enzymes are monomers. It is not possible to
predict the interaction site between the monomers
with confidence, however, it is unlikely that the left
side of the monomer as depicted in Fig. 3 forms the
dimer interface since it carries several glycosylation
sites. It is more likely that the other side of the protein
near loops L3 and L4 is part of the dimer interface. If a
domain rotation is also part of the catalytic cycle of the
mammalian enzymes, it might be speculated that the
two monomers interact only with the larger N-terminal
domains and not at the smaller C-terminal domain,
which rotates around its center in the E. coli enzyme.
It is at present not clear how the glycosylation sites
could modulate the enzyme activity [19], since they are
relatively far away from the active site. Asn-333 is
located close to the hinge region and its glycosylation
might influence a domain movement in ecto-50-NT
(Fig. 3). An influence of the different charge of the
heterogenously sialylated glycans by long-range elec-
trostatic interactions is also possible [19].
Dimetal site
The two metal ions in the active site of E. coli 50-NT
are 3.3 to 3.5 A˚ apart and are bridged monodentately
by an aspartate side chain and by a water molecule
(Fig. 4). Metal ion 1 is further ligated by an aspartate,
a glutamine and a histidine residue. A water molecule
completes the octahedral coordination sphere if Mn2+
is bound. Metal ion 2 is coordinated by two histidines
and an asparagine side chain as well as by a water
molecule, which is replaced by the phosphate group of
the substrate in the Michaelis complex. In the dizinc
enzyme both metal ions are five-coordinated since the
Fig. 2 Sequence alignment of E. coli, bovine, human and electric ray 50-nucleotidases. The secondary structure and the residue
numbering shown above the alignment are from the E. coli structure. Functionally important residues are marked below the alignment
with the following labels: F1_ and F2_ mark ligands to metal ions 1 and 2, respectively; the catalytic Asp–His dyad is labeled FC_; FR_
marks the three arginine side chains in the active site of the E. coli enzyme; FF_ are the phenylalanines that bind the adenine moiety;
residues that interact with the substrate by hydrogen bonding are marked with a capital FS_ whereas residues involved in non-polar
interactions are indicated by a lower-case Fs_. Cystine bridges of the bovine enzyme are marked by lines connecting the cysteines.
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terminal water ligands are missing [38]. The metal
ligands are all conserved in ecto-50-NT with the
exception of M1-ligand Gln254 which corresponds to
Asn245 in ecto-50-NT. It appears unlikely that the
shorter side chain supports metal coordination of
Asn245, but the Asn245 carboxamide group may bind
a water molecule which is coordinated to M1. This
situation is similar in the Ser/Thr protein phosphatases,
where also a water molecule is coordinated to M1 in
place of the Gln of E. coli 50-NT.
Substrate binding site
Structures of E. coli 50-NT in complex with the sub-
strate analogue inhibitor a,b-methylene-ADP revealed
the characteristics of the substrate binding pocket of
the C-terminal domain (Fig. 5). A central feature is the
hydrophobic stacking interaction of the adenine moi-
ety, which is sandwiched between two phenylalanine
side chains. The N1 nitrogen of the adenine ring is
recognized by the carboxamide group of Asn431. The
ribose group of the nucleotide is bound by Asp504, the
backbone oxygen of Gly458 and Arg410. Two further
arginines are in contact to the a- and b-phosphate
groups of the substrate.
Of these residues, the two phenylalanines are
conserved in the ecto-enzymes or in electric ray 50-
NT are replaced by a tyrosine, which should also
support the stacking interaction. Asn431 is replaced by
a glycine residue. There is no other side chain nearby
in the model which could replace the asparagine. Most
Fig. 3 Superposition of the C traces of the experimental X-ray structure of E. coli 5
0
-NT (protein C of PDB ID 1HPU; grey) and the
homology model for human 5
0
-NT. Larger insertions and deletions of the ecto-5
0
-NT are coloured in magenta and labeled L1 to L7. The closed
conformation of E. coli 5
0
-NT (protein C of PDB ID 1HPU) has been used as template for the homology modelling according to the sequence
alignment listed in Fig. 2). The exact loop conformations of longer insertions (L2, L3, L5 and L6) in ecto-5
0
-NT cannot be modeled with
confidence. The experimentally determined disulfide bridges of bovine 5
0
-NT are shown in yellow and the glycosylated asparagines are shown
in red. Depicted in dark blue is the substrate analogue inhibitor a,b-methylene-ADP.
Fig. 4 Scheme of the dimetal center and proposed structure of
the Michaelis complex for 50-NT catalysis. The binding mode of
the substrates terminal phosphate group is supported by the
binding mode of the inhibitor a,b-methylene-ADP. Residue
labels refer to human 50-NT. All residues except for Asn245 are
conserved in the E. coli enzyme. Therefore the coordination of
Asn245 via a water molecule to metal ion 1 is hypothetical. In
the bacterial enzyme Asn245 is replaced by a glutamine, which is
directly coordinated to the metal ion.
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likely, a water molecule interacts with N1 of the
adenine ring. The aspartate residue bound to the
hydroxyl groups of the ribose is conserved, as well as
two of the three arginines. Arg375 of the E. coli en-
zyme is replaced by a serine. Thus, from the differ-
ences in the substrate binding site it is not obvious how
the stronger substrate specificity of the mammalian
enzymes towards AMP (vs. ADP and ATP) is
achieved. Possibly, a control of the domain rotation
and thus the distance between the adenosine binding
site of the C-terminal domain and the catalytic metal
center of the N-terminal domain influences the activity
towards adenine nucleotides that differ in the distance
between the adenine moiety and the terminal phos-
phate group.
Catalytic mechanism
A complex structure with the inhibitor a,b-methylene-
ADP provides a model for the substrate binding mode
(Figs. 4 and 5) [30]. One oxygen atom of the terminal
phosphate group is coordinated to the site 2 metal
ion. In addition, the catalytic histidine and an arginine
bind and polarize the phosphate group for attack of
the nucleophile. The nucleophilic water is supposed to
Fig. 5 Binding mode of the substrate analogue inhibitor a,b-methylene-ADP. (a) Stereo view of the active site. The residues which are
not conserved in ecto-50-NT are depicted in broken lines. The labels refer to the human enzyme. The loop shown in green is predicted
to be shorter in the ecto-enzymes. It is labeled L7 in Fig. 3. The colouring of the protein domains is the same as in Fig. 1. (b) Scheme of
the interaction between the protein and the inhibitor. The upper label for each residue refers to human 50-NT and the bottom label to
E. coli 50-NT. All residues are conserved with the exception of Asn-431 of E. coli (shown in broken lines), which is a glycine in the
mammalian enzymes.
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be the terminal water coordinated to the site 1 metal
ion [30]. This water molecule is in a perfect position
for an in-line attack on the phosphorus atom. It is
located at a distance of 3.2 A˚ and the angle between
this water, the phosphorus atom, and the leaving group
is 155-. However, the metal bridging water ligand is
also a possible candidate for the nucleophile. The two
metal ions, the arginine and the catalytic histidine
stabilize the transition state. No protein residue is
positioned to protonate the leaving group. Therefore, a
water molecule might provide a proton for the leaving
group.
This model for the mechanism describes the chem-
ical steps to hydrolyze phosphate ester or anhydride
bonds. As mentioned before, in E. coli 50-NT a domain
rotation is necessary for catalytic activity, presumably
for substrate binding and product release. It is unclear
if a domain rotation is also part of the catalytic cycle
for the ecto-enzymes. The homology model indicates
that the active site might be somewhat more easily
accessible in ecto-50-NT due to the shorter loop L7.
Conclusions
The catalytic domain of extracellular 50-nucleotidases
in bacteria as well as mammals belongs to a large
superfamily of dinuclear metallophosphoesterases,
which hydrolyse very different substrates, including
phosphoproteins, nucleotides and nucleic acids. In 50-
NT, the substrate specificity is provided by the binding
pocket for the nucleoside in the unique C-terminal
domain. Based on several crystal structures of E. coli
50-NT, the tertiary structure, substrate-binding mode
and catalytic mechanism have been characterised. In
the absence of crystallographic data of the ecto-50-NTs,
a model can be built for the mammalian 50-NTs based
on the homology of both domains. Open questions are
if a domain rotation is also part of the catalytic cycle of
ecto-50-NT and the structure of the dimeric enzyme.
Although some differences in the active site structures
of ecto-50-NT and E. coli 50-NT can be derived from
the model, further experiments are necessary to verify
the homology model and to relate the structural
differences to the variation in substrate specificity.
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